Moderna Secures Favorable FDA Panel Recommendation for mRNA Flu Vaccine

A Food and Drug Administration advisory committee has unanimously recommended the approval of Moderna's mRNA-based influenza vaccine, mFlusiva, for adults aged 50 and older. The nine-member panel...